Cefpodoxime Dosing Frequency and Duration in Adults
For adults, cefpodoxime proxetil should be administered at 200-400 mg every 12 hours (twice daily), with treatment duration ranging from 5-14 days depending on the specific infection being treated. 1, 2
Standard Dosing by Indication
The FDA-approved dosing regimens for adults vary by infection type 2:
Respiratory Tract Infections
- Pharyngitis/tonsillitis: 100 mg every 12 hours for 5-10 days 2
- Acute community-acquired pneumonia: 200 mg every 12 hours for 14 days 2
- Acute bacterial exacerbations of chronic bronchitis: 200 mg every 12 hours for 10 days 2
- Acute maxillary sinusitis: 200 mg every 12 hours for 10 days 2
Other Infections
- Skin and skin structure infections: 400 mg every 12 hours for 7-14 days 2
- Uncomplicated urinary tract infection: 100 mg every 12 hours for 7 days 2
- Uncomplicated gonorrhea: 200 mg as a single dose 2
Key Administration Considerations
Cefpodoxime proxetil tablets must be administered with food to enhance absorption. 2 When taken with food, the area under the curve (AUC) increases by 21-33% compared to fasting conditions, and peak plasma concentrations are significantly higher (3.1 mcg/mL fed versus 2.6 mcg/mL fasted). 2
Guideline-Supported Regimens
The American Academy of Otolaryngology–Head and Neck Surgery endorses cefpodoxime proxetil at 200-400 mg twice daily as an appropriate first-line option for acute respiratory tract infections, acute otitis media, and acute bacterial rhinosinusitis. 1 The American Thoracic Society lists cefpodoxime 200 mg twice daily as an alternative regimen for community-acquired pneumonia in adults with comorbidities. 1
Current guidelines explicitly advise against altering the approved dosing intervals (every 12 hours) for cefpodoxime. 1
Special Populations
Renal Impairment
For patients with severe renal impairment (creatinine clearance <30 mL/min), extend the dosing interval to every 24 hours. 2 In patients on hemodialysis, administer the dose 3 times per week after dialysis, as approximately 23% of the administered dose is cleared during a standard 3-hour hemodialysis session. 2
Hepatic Impairment
No dosage adjustment is necessary in patients with cirrhosis, as cefpodoxime pharmacokinetics remain similar to healthy subjects regardless of ascites presence. 2
Elderly Patients
Elderly subjects do not require dosage adjustments unless they have diminished renal function, though the plasma half-life may extend to 4.2 hours versus 3.3 hours in younger subjects. 2
Clinical Efficacy Data
Research demonstrates that shorter treatment courses can be equally effective. A 5-day course of cefpodoxime proxetil 100 mg twice daily achieved 96.6% clinical response and 96.3% bacterial eradication in streptococcal pharyngotonsillitis, comparable to 10 days of phenoxymethyl penicillin. 3 The shorter duration also resulted in significantly better compliance (98% versus 84%). 3
Common Pitfalls
- Do not administer on an empty stomach: Absorption is significantly reduced without food 2
- Do not extend dosing intervals beyond 12 hours in patients with normal renal function: Guidelines explicitly warn against this practice 1
- Do not assume susceptibility in penicillin-nonsusceptible Streptococcus pneumoniae: Recent data shows that isolates nonsusceptible to oral penicillin (MIC >0.06 mg/L) cannot reliably predict cefpodoxime susceptibility, with only 78.4% categorical agreement 4